27.11.2013 • News • Active Ingredients • Biotechnology • Dede Willams

Glaxo SmithKline to Invest in Scottish Plant expansion

Glaxo SmithKline (GSK) has announced plans to invest £25 million in expanding its active ingredient formulating plant at Montrose, Scotland. The UK drug maker said it would locate production of four unspecified new entities at the site, where it is receiving more than £3 million in financial support from the local government of Angus and the business development agency Scottish Enterprise.

The company's latest investment in Scotland is in addition to the £100 million it previously announced it was spending at Montrose and at Irvine, Scotland, where it produces antibiotics. The two investments together will bring GSK's headcount in Scotland to around 750.

In related news, Scottish Enterprise has announced a new drive to promote industrial biotechnology in the country, aimed at increasing turnover from £189 million currently to £900 million by 2025. The global market is currently worth around £360 billion, according to estimates.

The agency said it planned to encourage more sustainable manufacturing processes, building on "existing strengths." Some 40 industrial biotechnology companies already have established a foothold in Scotland.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Top-Feature

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.